PET imaging of αvβ3 integrin expression in tumours with 68Ga-labelled mono-, di- and tetrameric RGD peptides

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 38, Issue 1, 2011, Pages 128-137

  Dijkgraaf, Ingrid ^a   Yim, Cheng Bin ^a,b   Franssen, Gerben M ^a   Schuit, Robert C ^c   Luurtsema, Gert ^d   Liu, Shuang ^e   Oyen, Wim J G ^a   Boerman, Otto C ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e PURDUE UNIVERSITY   (United States)

Author keywords

v 3 integrin receptor; 68Ga; Angiogenesis; MicroPET; Multimers

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; ARGINYLGLYCYLASPARTIC ACID; GALLIUM 68; INDIUM 111; OCTANOL; RADIOPHARMACEUTICAL AGENT; VITRONECTIN RECEPTOR; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING ASSAY; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG TARGETING; DRUG UPTAKE; FEMALE; IC 50; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN TARGETING;

ANIMALS; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DIMERIZATION; FEMALE; GALLIUM RADIOISOTOPES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTEGRIN ALPHAVBETA3; KIDNEY NEOPLASMS; MICE; OCTANOLS; OLIGOPEPTIDES; POSITRON-EMISSION TOMOGRAPHY; WATER;

EID: 79551515411     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-010-1615-x     Document Type: Article

References (38)

1. N Ferrara 2000 Vascular endothelial growth factor and the regulation of angiogenesis Recent Prog Horm Res 55 15 35 1:CAS:528:DC%2BD3MXitVGqsrs%3D 11036931
2. M Kuwano J Fukushi M Okamoto A Nishie H Goto T Ishibashi, et al. 2001 Angiogenesis factors Intern Med 40 565 572 1:CAS:528:DC%2BD3MXntFGgt7Y%3D 10.2169/internalmedicine.40.565 11506294
3. LM Ellis W Liu SA Ahmad F Fan YD Jung RM Shaheen, et al. 2001 Overview of angiogenesis: biologic implications for antiangiogenic therapy Semin Oncol 28 94 104 1:CAS:528:DC%2BD3MXpt1Wnsr8%3D 10.1016/S0093-7754(01)90287-8 11706401
4. GD Yancopoulos S Davis NW Gale JS Rudge SJ Wiegand J Holash 2000 Vascular-specific growth factors and blood vessel formation Nature 407 242 248 1:CAS:528:DC%2BD3cXmvVSlsrY%3D 10.1038/35025215 11001067
5. J Folkman 1995 Angiogenesis in cancer, vascular, rheumatoid and other disease Nat Med 1 27 31 1:CAS:528:DyaK2MXjs1KnsLk%3D 10.1038/nm0195-27 7584949
6. EF Plow TA Haas L Zhang J Loftus JW Smith 2000 Ligands binding to integrins J Biol Chem 275 21785 21788 1:CAS:528:DC%2BD3cXltFGjtrs%3D 10.1074/jbc.R000003200 10801897 (Pubitemid 30621742)
7. R Haubner D Finsinger H Kessler 1997 Stereoisomeric peptide libraries and peptidomimetics for designing selective inhibitors of the αvβ3 integrin for a new cancer therapy Angew Chem Int Ed Engl 36 1374 1389 1:CAS:528:DyaK2sXlsVert7g%3D 10.1002/anie.199713741
8. R Haubner HJ Wester WA Weber C Mang SI Ziegler SL Goodman, et al. 2001 Noninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptides and positron emission tomography Cancer Res 61 1781 1785 1:CAS:528:DC%2BD3MXit1Ohtbk%3D 11280722
9. R Haubner WA Weber AJ Beer E Vabuliene D Reim M Sarbia, et al. 2005 Noninvasive visualization of the activated alphavbeta3 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGD PLoS Med 2 e70 10.1371/journal.pmed.0020070 15783258 (Pubitemid 40629471)
10. AJ Beer R Haubner M Sarbia M Goebel S Luderschmidt AL Grosu, et al. 2006 Positron emission tomography using [18F]Galacto-RGD identifies the level of integrin alpha(v)beta3 expression in man Clin Cancer Res 12 3942 3949 1:CAS:528:DC%2BD28XmsValtLk%3D 10.1158/1078-0432.CCR-06-0266 16818691 (Pubitemid 44078079)
11. LM Kenny RC Coombes I Oulie KB Contractor M Miller TJ Spinks, et al. 2008 Phase I trial of the positron-emitting Arg-Gly-Asp (RGD) peptide radioligand 18F-AH111585 in breast cancer patients J Nucl Med 49 879 886 10.2967/jnumed.107.049452 18483090 (Pubitemid 351793427)
12. HR Maecke M Hofmann U Haberkorn 2005 (68)Ga-labeled peptides in tumor imaging J Nucl Med 46 Suppl 1 172S 178S 1:CAS:528:DC%2BD2MXhsVeksb0%3D 15653666
13. C Decristoforo I Hernandez Gonzalez J Carlsen M Rupprich M Huisman I Virgolini, et al. 2008 68Ga- and 111In-labelled DOTA-RGD peptides for imaging of alphavbeta3 integrin expression Eur J Nucl Med Mol Imaging 35 1507 1515 10.1007/s00259-008-0757-6 18369617
14. ZB Li K Chen X Chen 2008 (68)Ga-labeled multimeric RGD peptides for microPET imaging of integrin alpha(v)beta(3) expression Eur J Nucl Med Mol Imaging 35 1100 1108 1:CAS:528:DC%2BD1cXlvVClt70%3D 10.1007/s00259-007-0692-y 18204838
15. Z Liu G Niu J Shi S Liu F Wang S Liu, et al. 2009 (68)Ga-labeled cyclic RGD dimers with Gly3 and PEG4 linkers: promising agents for tumor integrin alphavbeta3 PET imaging Eur J Nucl Med Mol Imaging 36 947 957 1:CAS:528:DC%2BD1MXls1yjsL0%3D 10.1007/s00259-008-1045-1 19159928
16. I Dijkgraaf JA Kruijtzer C Frielink AC Soede HW Hilbers WJ Oyen, et al. 2006 Synthesis and biological evaluation of potent alphavbeta3-integrin receptor antagonists Nucl Med Biol 33 953 961 1:CAS:528:DC%2BD28Xht1Cls7%2FK 10.1016/j.nucmedbio.2006.08.008 17127167 (Pubitemid 44791955)
17. I Dijkgraaf JA Kruijtzer S Liu AC Soede WJ Oyen FH Corstens, et al. 2007 Improved targeting of the alpha(v)beta(3) integrin by multimerisation of RGD peptides Eur J Nucl Med Mol Imaging 34 267 273 1:CAS:528:DC%2BD2sXnvVSgsA%3D%3D 10.1007/s00259-006-0180-9 16909226 (Pubitemid 46147510)
18. S Liu E Cheung M Ziegler M Rajopadhye DS Edwards 2001 (90)Y and (177)Lu labeling of a DOTA-conjugated vitronectin receptor antagonist useful for tumor therapy Bioconjug Chem 12 559 568 1:CAS:528:DC%2BD3MXkt1Wktr8%3D 10.1021/bc000146n 11459461 (Pubitemid 32696230)
19. Y Wu X Zhang Z Xiong Z Cheng DR Fisher S Liu, et al. 2005 microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide J Nucl Med 46 1707 1718 1:CAS:528:DC%2BD28XitVGlt7o%3D 16204722
20. M Janssen C Frielink I Dijkgraaf W Oyen DS Edwards S Liu, et al. 2004 Improved tumor targeting of radiolabeled RGD peptides using rapid dose fractionation Cancer Biother Radiopharm 19 399 404 1:CAS:528: DC%2BD2cXnslOlsrc%3D 15453954
21. ML Janssen WJ Oyen I Dijkgraaf LF Massuger C Frielink DS Edwards, et al. 2002 Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model Cancer Res 62 6146 6151 1:CAS:528:DC%2BD38XosF2ms7w%3D 12414640
22. EP Visser JA Disselhorst M Brom P Laverman M Gotthardt WJ Oyen, et al. 2009 Spatial resolution and sensitivity of the Inveon small-animal PET scanner J Nucl Med 50 139 147 10.2967/jnumed.108.055152 19139188
23. R Haubner B Kuhnast C Mang WA Weber H Kessler HJ Wester, et al. 2004 [18F]Galacto-RGD: synthesis, radiolabeling, metabolic stability, and radiation dose estimates Bioconjug Chem 15 61 69 1:CAS:528:DC%2BD3sXpslWns7Y%3D 10.1021/bc034170n 14733584 (Pubitemid 38165981)
24. A Heppeler S Froidevaux H Mäcke E Jermann M Behe P Powell, et al. 1999 Radiometal-labelled macrocyclic chelator-derivatised somatostatin analogue with superb tumour-targeting properties and potential for receptor-mediated internal radiotherapy Chem Eur J 5 1974 1981 1:CAS:528:DyaK1MXksVansbY%3D 10.1002/(SICI)1521-3765(19990702)5:7<1974::AID-CHEM1974>3.0.CO;2-X
25. D Boturyn JL Coll E Garanger MC Favrot P Dumy 2004 Template assembled cyclopeptides as multimeric system for integrin targeting and endocytosis J Am Chem Soc 126 5730 5739 1:CAS:528:DC%2BD2cXivFems70%3D 10.1021/ja049926n 15125666 (Pubitemid 38621412)
26. T Poethko G Thumshirn U Hersel F Rau R Haubner M Schwaiger, et al. 2003 Improved tumor uptake, tumor retention and tumor/background ratios of pegylated RGD multimers J Nucl Med 44 46P
27. T Poethko M Schottelius G Thumshirn M Herz R Haubner G Henriksen, et al. 2004 Chemoselective pre-conjugate radiohalogenation of unprotected mono- and multimeric peptides via oxime formation Radiochim Acta 92 317 327 1:CAS:528:DC%2BD2cXmvVKlsbc%3D 10.1524/ract.92.4.317.35591
28. G Thumshirn U Hersel SL Goodman H Kessler 2003 Multimeric cyclic RGD peptides as potential tools for tumor targeting: solid-phase peptide synthesis and chemoselective oxime ligation Chem Eur J 9 2717 2725 1:CAS:528: DC%2BD3sXltVSiurw%3D 10.1002/chem.200204304
29. T Poethko M Schottelius G Thumshirn U Hersel M Herz G Henriksen, et al. 2004 Two-step methodology for high-yield routine radiohalogenation of peptides: (18)F-labeled RGD and octreotide analogs J Nucl Med 45 892 902 1:CAS:528:DC%2BD2cXnsFygtLc%3D 15136641
30. S Liu WY Hsieh Y Jiang YS Kim SG Sreerama X Chen, et al. 2007 Evaluation of a (99m)Tc-labeled cyclic RGD tetramer for noninvasive imaging integrin alpha(v)beta3-positive breast cancer Bioconjug Chem 18 438 446 10.1021/bc0603081 17341108 (Pubitemid 46493515)
31. I Vrasidas S André P Valentini C Böck M Lensch H Kaltner, et al. 2003 Rigidified multivalent lactose molecules and their interactions with mammalian galectins: a route to selective inhibitors Org Biomol Chem 1 803 810 1:CAS:528:DC%2BD3sXjt1Ggtbk%3D 10.1039/b210923a 12929363
32. LL Kiessling NL Pohl 1996 Strength in numbers: non-natural polyvalent carbohydrate derivatives Chem Biol 3 71 77 1:CAS:528:DyaK28XhvFKisr8%3D 10.1016/S1074-5521(96)90280-X 8807830 (Pubitemid 3036212)
33. Z Wu ZB Li K Chen W Cai L He FT Chin, et al. 2007 microPET of tumor integrin alphavbeta3 expression using 18F-labeled PEGylated tetrameric RGD peptide (18F-FPRGD4) J Nucl Med 48 1536 1544 1:CAS:528:DC%2BD2sXhtFGgsLnI 10.2967/jnumed.107.040816 17704249 (Pubitemid 47397404)
34. TM Behr DM Goldenberg W Becker 1998 Reducing the renal uptake of radiolabeled antibody fragments and peptides for diagnosis and therapy: present status, future prospects and limitations Eur J Nucl Med 25 201 212 1:CAS:528:DyaK1cXhtVWisLw%3D 10.1007/s002590050216 9473271 (Pubitemid 28130048)
35. R Max RR Gerritsen PT Nooijen SL Goodman A Sutter U Keilholz, et al. 1997 Immunohistochemical analysis of integrin alphavbeta3 expression on tumor-associated vessels of human carcinomas Int J Cancer 71 320 324 1:CAS:528:DyaK2sXjtleru7s%3D 10.1002/(SICI)1097-0215(19970502)71:3<320::AID- IJC2>3.0.CO;2-# 9139861 (Pubitemid 27224290)
36. J Haukkala I Laitinen P Luoto P Iveson I Wilson H Karlsen, et al. 2009 (68)Ga-DOTA-RGD peptide: biodistribution and binding into atherosclerotic plaques in mice Eur J Nucl Med Mol Imaging 36 2058 2067 1:CAS:528: DC%2BD1MXhsVCisb3I 10.1007/s00259-009-1220-z
37. ET Clarke AE Martell 1991 Stabilities of trivalent metal ion complexes of the tetraacetate derivatives of 12-, 13- and 14-membered tetraazamacrocycles Inorganica Chim Acta 190 37 46 1:CAS:528:DyaK38XitVajsLY%3D 10.1016/S0020- 1693(00)80229-7
38. ET Clarke AE Martell 1991 Stabilities of the Fe(III), Ga(III), and In(III) chelates of N,N′,N″-triazacyclononanetriacetic acid Inorganica Chim Acta 181 273 280 1:CAS:528:DyaK3MXksFyhu7Y%3D 10.1016/S0020-1693(00)86821-8